Efficient haemodialysis improves the response to hepatitis B virus vaccination

Intervirology

Volumn 45, Issue 3, 2002, Pages 172-176

  Kovacic, Vedran ^a,b   Sain, Milenka ^a   Vukman, Valentina ^a  

^a Health Centre   (Croatia)

^b NONE   (Croatia)

Author keywords

Haemodialysis; Hepatitis B; Vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; PRIORITY JOURNAL; VACCINATION;

ADULT; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RENAL DIALYSIS; VACCINATION;

HEPATITIS B VIRUS;

EID: 0036967850     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065873     Document Type: Article

References (29)

1. Hung KY, Chen WY, Yang CS, Lee SH, Wu DJ: Hepatitis B and C in hemodialysis patients. Dial Transplant 1995;24:135-139.
2. Propst T, Propst A, Lhotta K, Vogel W, Konig P: Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am J Kidney Dis 1998;32:1041-1045.
3. Oesterreicher C, Hammer J, Koch U, Pfeffel F, Sunder-Plassmann G, Petermann D: HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int 1995;48:1967-1971.
4. Buti M, Viladomiu L, Jardi R, Olmos A, Rodriguez JA, Bartolome J, Esteban R, Guardia J: Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol 1992;12:144-147.
5. Johnson DW, Fleming SJ: The use of vaccines in renal failure. Clin Pharmacokinet 1992;22:434-446.
6. Palmovic D, Crnjakovic-Palmovic J: Vaccination against hepatitis B: Results of the analysis of 2000 population members in Croatia. Eur J Epidemiol 1994;10:541-547.
7. Marangi AL, Giordano R, Montanaro A, De Padova F, Schiavone MG, Dongiovanni G: Hepatitis B virus infection in chronic uremia: Long-term follow-up of a two-step integrated protocol of vaccination. Am J Kidney Dis 1994;23:537-542.
8. Navarro JF, Teruel JL, Mateos ML, Marcen R, Ortuno J: Antibody level after hepatitis B vaccination in hemodialysis patients: Influence of hepatitis C virus infection. Am J Nephrol 1996;16:95-97.
9. National Kidney Foundation-Dialysis Outcome Quality Initiative (NKF-DOQI): Clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis 1997;30:22-63.
10. Rault R, Freed B, Nespor S, Bender F: Efficacy of different hepatitis B vaccination strategies in patients receiving hemodialysis. ASAIO J 1996;41:717-719.
11. Zeltzer E, Bernheim J, Korzets Z, Rathaus M, Mekori YA, Hershkoviz R: Diminished adhesion of CD4+ T cells from dialysis patients to extracellular matrix and its components fibronectin and laminin. Nephrol Dial Transplant 1997;12:2618-2622.
12. Vlassopoulos D, Arvanitis D, Lilis D, Hatjiyannakos D, Louizou K, Hadjiconstantinou V: Complete success of intradermal vaccination against hepatitis B in advanced chronic renal failure and hemodialysis patients. Renal Fail 1997;19:455-460.
13. Fabrizi F, Andrulli S, Bacchini G, Corti M, Locatelli F: Intradermal versus intramuscular hepatitis B re-vaccination in non-responsive chronic dialysis patients: A prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Transplant 1997;12:1204-1211.
14. Chang PC, Schrander-van der Meer AM, Van Dorp WT, Van Leer E: Intracutaneous versus intramuscular hepatitis B vaccination in primary non-responding haemodialysis patients. Nephrol Dial Transplant 1996;11:191-193.
15. Waite NM, Thomson LG, Goldstein MB: Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine. J Am Soc Nephrol 1995;5:1930-1934.
16. El-Reshaid K, Al-Mufti S, Johny KV, Sugathan TN: Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients. Vaccine 1994;12:223-234.
17. Fernandez E, Betriu MA, Gomez R, Montoliu J: Response to the hepatitis B virus vaccine in haemodialysis patients: Influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant 1996;11:1559-1563.
18. Khan AN, Bernardini J, Rault RM, Piraino B: Low seroconversion with hepatitis B vaccination in peritoneal dialysis patients. Peritoneal Dial Int 1996;16:370-373.
19. Navarro JF, Teruel JL, Mateos M, Ortuno J: Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients. Clin Nephrol 1994;41:113-116.
20. Lombardi M, Pizzarelli F, Righi M, Cerrai T, Dattolo P, Nigrelli S: Hepatitis B vaccination in dialysis patients and nutritional status. Nephron 1992;61:266-268.
21. Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994;23/2:272-282.
22. Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, Bloembergen WE, Greer JW, Hakim RM: The dose of hemodialysis and patient mortality. Kidney Int 1996;50/2:550-556.
23. Parker T, Husni L, Huang W, Lew N, Lowrie EG, Dallas Nephrology Associates: Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994;23:670-680.
24. Sobh MA, Sheashaa H, Tantawy AEH, Ghoneim MA: Study of effect of optimization of dialysis and protein intake on neuromuscular function in patients under maintenance hemodialysis treatment. Am J Nephrol 1998;18:399-403.
25. Depner T, Beck G, Daugirdas J, Kusek J, Eknoyan G: Lessons from the Hemodialysis (HEMO) Study: An improved measure of the actual hemodialysis dose. Am J Kidney Dis 1999;33:142-149.
26. Gotch FA: Kt/V is the best dialysis dose parameter. Blood Purif 2000;18:276-285.
27. Gotch FA, Sargent JA, Keen ML: Whither goest Kt/V? Kidney Int Suppl 2000;76:3-18.
28. Skroeder NR, Kjellstrand P, Holmquist B, Nilsson U, Jacobson SH: Increased amounts of C3a and the terminal complement complex at high dialysis blood flow: The relation with dialysis efficiency. Nephron 1996;72:523-529.
29. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanovski JA, Veis JH: Immunologic function and survival in hemodialysis patients. Kidney Int 1998; 54:236-244.